Scilex Holding

SCLX | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.33

+$0.29 (+5.75%)

Sep 21, 2026, 9:39 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.75%

(1D)

Rating

Updated: Aug 14, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $45.29M

1D Range

5 5.33

52W Range

2.62 21.34

Valuation (TTM)

PE -0.10

PB -0.14

EV/EBITDA -0.38

Valuation (NTM)

Forward PE 8.53

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -41.9%

SBC Adj. FCF Yield -66.4%

SBC Impact -58.5%

Margins

Gross Margin 41.5%

Operating Margin -903.5%

FCF Margin -56.7%

Growth (CAGR)

Revenue 3Y | 5Y -12.1% | 3.6%

Dil EPS 3Y | 5Y -22.4% | -42.2%

FCF 3Y | 5Y -319.2% | 82.8%

Returns

ROA -176.3%

ROE 189.8%

ROIC 162.6%

Financial Health

Net Debt

$94.98M

Current Ratio 0.07

Interest Coverage -17.65

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its prim...

Sector Healthcare

Industry Drug Manufacturers - General

Employees 34

IPO Date Mar 4, 2021

Website www.scilexholding.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞